Reverse DCF
What growth does the market imply for GUFICBIO?
Working backwards from the current price to find the FCF growth assumption baked in.
very aggressive
24.5% implied annual FCF growth
The market is pricing in exceptional growth that only a handful of companies sustain for a decade. For context, this company has historically grown at -1.3%. High execution risk.
Current Price
₹297
Historical Growth
-1.3%
FCF Yield
1.58%
Price / FCF
63.2x
Plain English
To justify today's price of $296.50, GUFICBIO.NS needs to grow its free cash flow at 24.5% per year for the next 10 years. That is 25.8% faster than its historical growth rate of -1.3%. At its historical growth rate, the stock cannot justify its current price within a 20-year horizon. The market is pricing in a step-change in performance.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Historical | -1.3% | ₹15 | -95.0% |
| GDP rate | 10.0% | ₹77 | -74.0% |
| Half implied | 12.2% | ₹98 | -67.1% |
| Implied | 24.5% | ₹299 | +0.8% |
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, Monte Carlo, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.